{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome uvéo-méningo-encéphalique : Questions médicales les plus fréquentes",
"headline": "Syndrome uvéo-méningo-encéphalique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome uvéo-méningo-encéphalique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-18",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome uvéo-méningo-encéphalique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies auto-immunes du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D020274",
"about": {
"@type": "MedicalCondition",
"name": "Maladies auto-immunes du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D020274",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.111.258"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome uvéo-méningo-encéphalique",
"alternateName": "Uveomeningoencephalitic Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D014607",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Leen Alblaihed",
"url": "https://questionsmedicales.fr/author/Leen%20Alblaihed",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA. Electronic address: https://twitter.com/LeenAlblaihed."
}
},
{
"@type": "Person",
"name": "Maite Anna Huis In 't Veld",
"url": "https://questionsmedicales.fr/author/Maite%20Anna%20Huis%20In%20%27t%20Veld",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency Medicine, Elisabeth TweeSteden Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, the Netherlands; Department of Emergency Medicine, University of Maryland School of Medicine, MD, USA. Electronic address: m.huisintveld@etz.nl."
}
},
{
"@type": "Person",
"name": "Yehuda Shoenfeld",
"url": "https://questionsmedicales.fr/author/Yehuda%20Shoenfeld",
"affiliation": {
"@type": "Organization",
"name": "Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer 5265601, Ramat-Gan; Reichmann University, Herzliya, Israel."
}
},
{
"@type": "Person",
"name": "Rosanna Fulchiero",
"url": "https://questionsmedicales.fr/author/Rosanna%20Fulchiero",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA."
}
},
{
"@type": "Person",
"name": "Patricia Seo-Mayer",
"url": "https://questionsmedicales.fr/author/Patricia%20Seo-Mayer",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Inova Children's Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA; Division of Nephrology and Hypertension, Pediatric Specialists of Virginia, 3023 Hamaker Court, Suite 600, Fairfax, VA 22031, USA; Virginia Commonwealth School of Medicine, Richmond, VA, USA. Electronic address: Pseo-mayer@psvcare.org."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Variations in the Termination of the Popliteal Artery: A Multidetector Computed Tomography Angiography (CTA)-Based Retrospective Study.",
"datePublished": "2024-06-25",
"url": "https://questionsmedicales.fr/article/39055442",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.63092"
}
},
{
"@type": "ScholarlyArticle",
"name": "Terminal sequence consistency verification method for small diameter abreast optical fibers based on computer vision.",
"datePublished": "2024-08-12",
"url": "https://questionsmedicales.fr/article/39309945",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.heliyon.2024.e35998"
}
},
{
"@type": "ScholarlyArticle",
"name": "Novel Two-Terminal Synapse/Neuron Based on an Antiferroelectric Hafnium Zirconium Oxide Device for Neuromorphic Computing.",
"datePublished": "2024-08-15",
"url": "https://questionsmedicales.fr/article/39148056",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.nanolett.4c02142"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tear film changes in symptomatic versus asymptomatic video display terminal users following computer challenge test.",
"datePublished": "2023-08-16",
"url": "https://questionsmedicales.fr/article/37595798",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtos.2023.08.003"
}
},
{
"@type": "ScholarlyArticle",
"name": "Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37513989",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/pharmaceutics15071802"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies auto-immunes",
"item": "https://questionsmedicales.fr/mesh/D001327"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies auto-immunes du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D020274"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndrome uvéo-méningo-encéphalique",
"item": "https://questionsmedicales.fr/mesh/D014607"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome uvéo-méningo-encéphalique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome uvéo-méningo-encéphalique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome uvéo-méningo-encéphalique",
"description": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes cliniques indiquent ce syndrome ?\nLe syndrome peut-il être confondu avec d'autres maladies ?\nQuelle est l'importance de l'analyse du LCR ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Computer+Terminals&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome uvéo-méningo-encéphalique",
"description": "Quels sont les symptômes principaux du syndrome ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir de la fièvre avec ce syndrome ?\nLes symptômes sont-ils toujours présents ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Computer+Terminals&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome uvéo-méningo-encéphalique",
"description": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?\nLes vaccinations sont-elles efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nY a-t-il des groupes à risque ?\nLes voyages augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Computer+Terminals&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome uvéo-méningo-encéphalique",
"description": "Quel est le traitement principal du syndrome ?\nLes antibiotiques sont-ils nécessaires ?\nComment gérer les symptômes neurologiques ?\nY a-t-il des traitements préventifs ?\nQuelle est la durée du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Computer+Terminals&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome uvéo-méningo-encéphalique",
"description": "Quelles sont les complications possibles ?\nLe syndrome peut-il entraîner des séquelles à long terme ?\nY a-t-il un risque de récidive ?\nComment surveiller les complications ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Computer+Terminals&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome uvéo-méningo-encéphalique",
"description": "Quels sont les facteurs de risque connus ?\nL'âge influence-t-il le risque ?\nLes antécédents médicaux jouent-ils un rôle ?\nL'environnement peut-il affecter le risque ?\nLes voyages à l'étranger augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014607?mesh_terms=Computer+Terminals&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le syndrome uvéo-méningo-encéphalique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'imagerie cérébrale et des analyses de liquide céphalorachidien."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des IRM, des tomodensitométries et des analyses de sang et de LCR sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent ce syndrome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des maux de tête, des troubles visuels et des convulsions peuvent indiquer le syndrome."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec d'autres infections neurologiques comme la méningite bactérienne."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'analyse du LCR ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse du LCR permet de détecter des signes d'inflammation et d'infection, cruciaux pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux du syndrome ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des troubles de la vision, et des signes neurologiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des convulsions, des troubles de la conscience et des déficits neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Peut-on avoir de la fièvre avec ce syndrome ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre est un symptôme fréquent, souvent accompagnée de signes d'inflammation."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent présenter des symptômes légers ou intermittents."
}
},
{
"@type": "Question",
"name": "Comment prévenir le syndrome uvéo-méningo-encéphalique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la vaccination contre les infections virales et l'hygiène personnelle."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infections virales associées au syndrome."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le contact avec des personnes malades sont recommandés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des groupes à risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées et celles vivant dans des zones d'épidémie sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où des infections virales sont endémiques peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal inclut des antiviraux, des corticostéroïdes et des soins de soutien."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques ne sont pas efficaces contre les infections virales, mais peuvent être utilisés si une infection bactérienne est suspectée."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes neurologiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes neurologiques peuvent être gérés par des anticonvulsivants et des soins neurologiques spécialisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements préventifs spécifiques pour ce syndrome."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie selon la gravité de l'infection et la réponse au traitement, souvent plusieurs semaines."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des séquelles neurologiques, des troubles de la vision et des crises épileptiques."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il entraîner des séquelles à long terme ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer des séquelles neurologiques à long terme après le traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de récidive dépend de la cause sous-jacente et de l'état immunitaire du patient."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier avec des examens neurologiques et des imageries est essentiel pour surveiller les complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et approprié de l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, les infections virales antérieures et l'exposition à des vecteurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont souvent plus à risque de développer ce syndrome."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'infections neurologiques augmentent le risque de développer ce syndrome."
}
},
{
"@type": "Question",
"name": "L'environnement peut-il affecter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des zones où des infections virales sont fréquentes augmente le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où des épidémies d'infections virales sont présentes peut augmenter le risque."
}
}
]
}
]
}
Comprehension of the intrucate anatomy and variations in the termination of the popliteal artery (PA) is increasingly essential for endovascular interventionists, plastic surgeons, vascular surgeons, ...
A retrospective review of CTA images of 181 lower extremities from 100 patients (137 males and 44 females), aged five to 75 years, was conducted....
The usual type I-A pattern was found in 75.69% of cases, while 24.31% exhibited variant patterns. Type III was the most common variation observed (19.34%), with type III-A being the most prevalent (11...
There is a high prevalence of variation in the termination pattern of the PA. Knowledge of these variations is crucial for any interventions in this region to avoid postoperative vascular complication...
In a kind of precision industrial equipment, small diameter abreast optical fibers are used for high-speed communication among functional nodes. The arrangement order at both terminals of the abreast ...
Functionally diverse devices with artificial neuron and synapse properties are critical for neuromorphic systems. We present a two-terminal artificial leaky-integrate-fire (LIF) neuron based on 6 nm H...
To assess the real-time changes in the tear film and ocular surface of symptomatic video display terminal (VDT) versus asymptomatic users....
A total of 35 symptomatic (29 ± 5.6 years; Group 1, mild dry eye disease) and 35 asymptomatic (24.1 ± 4.6 years; Group 2) VDT users with a mean OSDI of 28 ± 11 and 0.86 ± 2.1, respectively, had tear f...
The mean VDT use was 11.4 ± 3.2 h/day in Group 1 and 2.3 ± 2.3 h/day in Group 2. In Group 1, the mean pre- and post-VDT task values for NIBUT and bulbar congestion were 10.7 ± 3.7s and 6.7 ± 3.1s (P =...
Tear film instability and increased bulbar congestion are observed in symptomatic VDT users after computer work despite baseline stable tear film. The changes are significantly altered in symptomatic ...
By exploiting ion transport phenomena in a soft and flexible discrete channel, liquid material conductance can be controlled by using an electrical input signal, which results in analog neuromorphic b...
Suspended respirable airborne particles are associated with human health risks and especially particles within the range of ultrafine (< 0.1 μm) or fine (< 2.5 μm) have a high possibility of penetrati...
The realistic bronchi up to the 8...
Here, we report reliable results of airflow patterns and particle deposition efficiency in the human respiratory system validated against experimental data. The individual-related focal point of ultra...
From the results, the developed realistic human respiratory system down to the terminal bronchiole in this study, in coupling with the CFPD method, delivers the accurate prediction of a wide range of ...
Deciding on "termination of resuscitation" (TOR) is a dilemma for any physician facing cardiac arrest. Due to the lack of evidence-based criteria and scarcity of the existing guidelines, crucial arbit...
Evaluate with a quantitative method the existence of a physician internal bias to terminate resuscitation....
We extracted data concerning OHCAs managed between January 2013 and September 2021 from the RéAC registry. We conducted a statistical analysis using generalized linear mixed models to model the binary...
5,144 OHCAs involving 173 physicians were included. The cohort's average age was 69 (SD 18) and was composed of 62% of women. Median no-flow and low-flow times were respectively 6 (IQR [0,12]) and 18 ...
We demonstrate the existence of individual physician biases in their decision about TOR. The impact of this bias is greater than that of a no-flow duration lasting ten to twenty minutes. Our results p...
In this article, effects of di-, tetra-, and octafluorination on the structural and chiroptical properties of carbo[5-8]helicenes are reported. Three fluorinated derivatives are designed from each par...